Medicine and Dentistry
Patient
100%
Haemophilia
97%
Therapeutic Procedure
71%
Prophylaxis
49%
Patient with Hemophilia
26%
Health
21%
Quality of Life
21%
Adult
20%
Person
19%
Development
18%
Age
13%
Immunological Tolerance
12%
Pain
11%
Life
11%
Systematic Review
11%
Disease
11%
Surgery
10%
Experience
9%
Bleeding
9%
Gene Therapy
8%
Drug Megadose
8%
Follow up
8%
Myelodysplastic Syndrome
8%
Substitution Therapy
7%
Child
7%
Therapeutics
6%
Complication
6%
Blood Stasis
6%
Cancer
5%
Family
5%
Bone Density
5%
Post-Hoc Analysis
5%
Genetic Risk Factor
5%
Blood Clotting Factor Concentrate
5%
Comorbidity
5%
Odds Ratio
5%
Association
5%
Pharmacology, Toxicology and Pharmaceutical Science
Haemophilia A
39%
Blood Clotting Factor 8
22%
Ciclonicate
14%
Replacement Therapy
12%
Pharmacokinetics
11%
Antibodies
11%
Recombinant Blood Clotting Factor 8
9%
Chemotherapy
8%
Activated Prothrombin Complex
7%
Cohort Study
6%
Von Willebrand Factor
6%
Incidence
6%
Biochemistry, Genetics and Molecular Biology
Factor IX
23%
Gene
18%
Epidermal Growth Factor
13%
Carboxyglutamic Acid
11%
Genetics
10%
Genetic Determinism
9%
Inversion
9%
Factor X
8%
Droplet Digital Polymerase Chain Reaction
8%
Allele
7%
N-Terminus
7%
Serine Protease
6%
Immune Response
5%
